The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by N’Diaye, E.-N.
Right arrow Articles by Maridonneau-Parini, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by N’Diaye, E.-N.
Right arrow Articles by Maridonneau-Parini, I.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1998, 161: 4983-4991.
Copyright © 1998 by The American Association of Immunologists

Fusion of Azurophil Granules with Phagosomes and Activation of the Tyrosine Kinase Hck Are Specifically Inhibited During Phagocytosis of Mycobacteria by Human Neutrophils1

Elsa-Noah N’Diaye*, Xavier Darzacq*, Catherine Astarie-Dequeker*, Mamadou Daffé*, Jero Calafat{dagger} and Isabelle Maridonneau-Parini2,*

* Institut de Pharmacologie et de Biologie Structurale–Centre National de la Recherche Scientifique, Unité Propre de Recherche 9062, Toulouse, France; and {dagger} The Netherlands Cancer Institute, Amsterdam, The Netherlands


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Pathogenic mycobacteria parasitize macrophages and reside within phagosomes, which do not fuse with lysosomal granules. Mycobacteria are also internalized by neutrophils, which possess at least two types of granules, specific and azurophil granules, the latter being specialized lysosomes. Here, we investigated the ability of mycobacteria to inhibit the fusion of these granules with their phagosomes in human neutrophils. It was found that when pathogenic (Mycobacterium kansasii and Mycobacterium avium) or nonpathogenic (Mycobacterium smegmatis and Mycobacterium phlei) mycobacteria were internalized by neutrophils, they induced the inhibition of azurophil granule fusion with phagosomes even when they were serum opsonized. In contrast, secretion of specific granule content and production of O2-, both of which contribute to the neutrophil bactericidal response, were triggered. Hck is a Src family tyrosine kinase associated with azurophil granules. During internalization of zymosan, azurophil granules fused with phagosomes and Hck was activated and translocated to the phagosomal membrane, whereas in neutrophils engulfing mycobacteria, Hck did not translocate and remained unactivated. The activation of the tyrosine kinase Fgr was not affected. These results indicate that 1) pathogenic and nonpathogenic mycobacteria trigger similar bactericidal responses in neutrophils, 2) phagocytosis and fusion of azurophil granules can be uncoupled by mycobacteria, and 3) Hck could be one of the key elements of the azurophil secretory pathway that are altered during phagocytosis of mycobacteria.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Neutrophils and macrophages participate in host defense by three mechanisms that lead to the destruction of invading microorganisms: phagocytosis of the infectious particles, generation of toxic oxygen derivatives through the activation of the NADPH oxidase, and release of microbicidal molecules from their granules (1).

Pathogenic mycobacteria are facultative intracellular parasites that are able to survive and replicate within macrophages (2). In addition to the well-known pathogenic species Mycobacterium tuberculosis and Mycobacterium leprae, opportunistic pathogenic mycobacteria have attracted epidemiologic interest since they cause infections in immunocompromised people. Two major opportunistic species, Mycobacterium avium and Mycobacterium kansasii, have frequently been isolated from pulmonary and disseminated infections in AIDS patients (3, 4). In macrophages, Mycobacterium microti, Mycobacterium marinum, M. avium, and M. tuberculosis inhibit the fusion between lysosomal granules and their phagosomes (5, 6, 7, 8, 9, 10), leading to the proposal that these properties favor their survival in macrophages (2).

Macrophages have long been regarded as the key phagocytic cells in mycobacterial infections. However, neutrophils have emerged as playing a significant protective role in tuberculosis (11, 12, 13). In contrast to macrophages, which contain only lysosomes (14), neutrophils contain at least two types of secretory granules, the azurophil and specific granules (15). Azurophil granules are a special class of lysosomes that, in addition to typical lysosomal enzymes, store bactericidal proteins and neutral proteases. Specific granules also contain proteins implicated in the bactericidal function of neutrophils, and they are a reservoir of plasma membrane receptors and cytochrome b558, a component of the NADPH oxidase complex (15). Proteins controlling the process of mobilization/fusion of these granules with the phagosomal or the plasma membrane have not yet been identified. Several reports suggest that a tyrosine kinase of the Src family, Hck, the expression of which is restricted to phagocytes (16), could be involved in this process: 1) it is mainly associated with the membrane of azurophil granules (17); 2) in the course of phagocytosis of opsonized zymosan, azurophil granules fuse with phagosomes and Hck translocates to the phagosomal membrane (17); 3) during this process, Hck is activated in the granular fraction and, to a lesser extent, in the phagosomal fraction (18); and 4) tyrosine kinase inhibitors inhibit the degranulation process (16).

Although neutrophils play a defensive role during mycobacterial infections (11, 12, 13), few data regarding bactericidal responses of neutrophils toward mycobacteria (19, 20, 21, 22) are available, e.g., mobilization of granules in response to mycobacteria has not been studied. In this paper, the release of azurophil and specific granule content was determined in human neutrophils during the phagocytosis of pathogenic (M. avium and M. kansasii) and nonpathogenic (Mycobacterium phlei and Mycobacterium smegmatis) mycobacteria. The tyrosine kinase activity of Hck was also studied.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents

Ficoll and PMSF were purchased from Eurobio (Les Ullis, France). MEM and HEPES were purchased from Life Technologies (Cergy Pontoise, France). Leupeptin, aprotinin, pepstatin, diisopropylfluorophosphate, and FITC were purchased from Sigma (St. Louis, MO). Anti-myeloperoxidase Abs (23) were from CLB (Amsterdam, The Netherlands); anti-lactoferrin was from Cappel Laboratories (Cochranville, PA); and anti-rabbit Abs gold conjugates were from Amersham Nederlands (s’Hertogenbosch, The Netherlands).

Human neutrophils

Neutrophils were isolated from the blood of healthy donors, separated by the Dextran-Ficoll method as previously described (24), resuspended in MEM, 10 mM HEPES, pH 7.4, and maintained for 20 min at 37°C before stimulation. The final suspensions contained ~95% neutrophils.

Bacteria strains and growth conditions

M. phlei (ATCC 11758), M. smegmatis (ATCC 607), and M. kansasii (ATCC 124478) (all from American Type Culture Collection (ATCC), Manassas, VA) were grown at 37°C as surface pellicles in 250-ml flasks containing 100 ml of Sauton broth medium. The medium was discarded, and the pellicles were disrupted by gentle shaking with glass beads (4-mm diameter) for 30 s and resuspended in PBS, pH 7.4. When another method to individualize mycobacteria was used, by passing bacteria through a narrow gauge syringe needle (0.45-mm diameter), the phagocyte responses studied herein were similar. In contrast to the other mycobacteria, it was not necessary to use beads for M. avium (IP140310013), which was cultured in Middlebrook 7H9 medium (Difco, Bonneuil sur Marne, France) with agitation in a New Brunswick incubator (125 rpm; New Brunswick Scientific, Edison, NJ). The culture was centrifuged at 10,000 x g for 10 min, and the pellet was resuspended in PBS. To remove clumps, the bacterial suspensions were sedimented for 10 min, and the supernatants were collected and centrifuged for 10 min at 200 x g. Supernatants were collected, counted under a microscope in a Thoma chamber, supplemented with 5% glycerol, and stored at -80°C until use. At least 90% of the mycobacteria were individualized, and the remaining 10% formed small aggregates containing two or three bacilli. Bacillus subtilis (ATCC 6633) was grown overnight in Tryptase-Soja broth (Biomerieux, Lyon, France) at 37°C, washed in PBS, and stored under the same conditions as the mycobacteria. All experiments were performed using a bacteria:phagocyte ratio of 50:1.

FITC staining of bacteria

Bacteria were stained with FITC as previously described (25). Briefly, 109 bacteria were added to 1 ml 0.01% FITC in 0.2 M Na2CO3/NaHCO3 buffer, pH 10.2, for 10 min. The bacteria were then washed twice in PBS, pH 7.4.

Opsonization of bacteria and zymosan

Bacteria or zymosan were incubated in pooled human sera for 20 min at 37°C, washed twice with PBS, pH 7.4, and resuspended in the same buffer containing 1 mM CaCl2 and 0.5 mM MgCl2 (24). Opsonization was checked by incubating bacteria or zymosan with FITC-coupled rabbit Abs directed against human IgG. Fluorescence was measured by FACScan analysis (Becton Dickinson, San Jose, CA).

Phagocytosis measurement and indirect immunofluorescence

Neutrophils (7 x 105/ml) adhering on glass coverslips were incubated at 37°C for 20 min in MEM-HEPES as previously described (26) and exposed to FITC-stained mycobacteria. Cells were then washed and fixed with 3.7% paraformaldehyde in PBS containing 15 mM sucrose, pH 7.4, for 30 min at room temperature. After neutralizing with 50 mM NH4Cl, slides were washed with PBS, pH 7.4, and mounted with 5 mg/ml trypan blue (27) to quench FITC-coupled bacteria remaining in the extracellular medium. Cells containing fluorescent mycobacteria were counted by alternately viewing them by phase contrast and fluorescence microscopy. For each condition, at least 100 cells were counted.

For immunolocalization of Hck, adherent neutrophils were fixed and permeabilized by plunging the glass coverslips into methanol at -20°C for 6 min, washed in PBS containing 0.1% Tween-20, then exposed to affinity-purified anti-Hck Abs (Santa Cruz Biotechnologies, Santa Cruz, CA), and then to FITC- or rhodamine-conjugated secondary Abs as previously described (17).

Immuno-electron microscopy

Neutrophils were fixed in 0.5% (v/v) glutaraldehyde and 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer, pH 7.2, for 2 h and then pelleted in 10% (w/v) gelatin in PBS. Ultrathin frozen sections were incubated at room temperature with mouse monoclonal anti-human myeloperoxidase (1:200) (23) or rabbit anti-human lactoferrin (1:400) followed by incubation with secondary Abs linked to 10-nm gold particles (dilution 1:40). All incubations were performed for 1 h. Ultrathin cryosections incubated with irrelevant control rabbit or murine Abs under the same conditions produced negligible background labeling. After immunolabeling, the cryosections were embedded in a mixture of methylcellulose and uranyl acetate and examined with a Philips CM10 electron microscope (Eindhoven, The Netherlands).

O2- production

The production of O2- was measured using the superoxide dismutase-inhibitable ferricytochrome c reduction method, as previously described (28).

Immunoblots

Control or stimulated neutrophils (5 x 106/ml) were disrupted and fractionated as previously described (28). Membrane (1 x 107 cell equivalents) and cytosolic proteins (5 x 106 cell equivalents) were loaded on a 12% SDS-PAGE gel, transferred onto a nitrocellulose membrane, blotted with p47phox and p67phox polyclonal Abs (kindly provided by A. Segal, London, U.K.), and revealed by enhanced chemiluminescence.

Protein exocytosis

Control or stimulated neutrophils (5 x 106/ml) were pelleted and the supernatants were centrifuged (10,000 x g for 10 min) to eliminate bacteria. Cell pellets lysed in Triton X100 and cell supernatants were stored at -80°C until used. Lysozyme was measured in the extracellular medium and in the cells by following the hydrolysis of Micrococcus sp at 450 nm, as previously described (29). Myeloperoxidase and lactoferrin were measured by ELISA as previously described (17). The enzyme activity of ß-glucuronidase was measured at 405 nm as previously described (30).

In some experiments, for quantification of cell death, release of the cytosolic enzyme lactate dehydrogenase was measured using the colorimetric assay kit from Boehringer (Meylan, France) according to the manufacturer’s instructions.

Kinase assays

Proteins were solubilized from neutrophils with a buffer containing 2% Nonidet P-40 and cytosol from NB4 cells to avoid proteolysis, as previously described (17). Kinases were immunoprecipitated and assayed for in vitro kinase activity in the presence of acid-treated enolase as exogenous substrate, 10 mM MnCl2, 10 µM MgCl2, and 10 µCi of [{gamma}-32P]ATP (6000 mCi/mmol) as described (17, 31). The specificity of the rabbit anti-Hck antiserum has been characterized previously (17), and affinity-purified anti-Fgr and anti-Lyn IgG (Santa Cruz Biotechnology) were used as described previously (31). The radioactivity incorporated in enolase was quantified using the ImageQuant program on the Storm840 imager, Molecular Dynamics (Sunnyvale, CA).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Internalization of mycobacteria by human neutrophils

The ability of neutrophils to engulf pathogenic and nonpathogenic mycobacteria was examined. Human neutrophils internalized both pathogenic and nonpathogenic mycobacteria under nonopsonic conditions (Fig. 1Go). Opsonization of mycobacteria in human serum enhanced the percentage of cells with engulfed bacteria (Fig. 1Go).



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 1. Phagocytosis of mycobacteria by human neutrophils. FITC-labeled mycobacteria were serum-opsonized (ops +) or not opsonized (ops -). Neutrophils were exposed to mycobacteria (cell:bacteria ratio, 1:50) for 40 min at 37°C. Cells were washed and fixed, and nonphagocytosed mycobacteria were quenched using trypan blue as described in Materials and Methods. The percentage of cells with >=1 fluorescent bacterium was determined by fluorescence microscopy (see Fig. 8Go). M. smeg., M. smegmatis. Results are expressed as mean ± SD of three independent experiments.

 
Selective inhibition of azurophil granule exocytosis by mycobacteria

We first examined whether neutrophils degranulate when exposed to mycobacteria. The release of lysozyme, a hydrolase present predominantly in specific but also in azurophil granules (1), was measured. In these experiments and the following, opsonized zymosan was used as a positive control. Pathogenic as well as nonpathogenic mycobacteria induced the exocytosis of lysozyme to similar extents (Fig. 2Go). Next, we studied whether the release of lysozyme could be modified when mycobacteria were serum opsonized. Under these conditions, the percentage of cells engulfing opsonized mycobacteria had approximately doubled (data not shown), but the exocytosis of lysozyme was comparable with that obtained with nonopsonized mycobacteria (Fig. 2Go).



View larger version (29K):
[in this window]
[in a new window]
 
FIGURE 2. Pathogenic and nonpathogenic mycobacteria trigger the release of lysozyme. Resting neutrophils (C, control) and neutrophils exposed to serum-opsonized (ops +) or nonopsonized (ops -) mycobacteria (cell:bacteria ratio, 1: 50) or to 3 mg/ml opsonized zymosan (Z), as a positive control, were incubated for 40 min at 37°C. The release of lysozyme is expressed as the percent of the total lysozyme cell content (mean ± SD of three experiments). *, p < 0.05 when compared with control calculated with unpaired Student’s t test.

 
To examine the mobilization of azurophil and specific granules independently, exocytosis of myeloperoxidase, an azurophil granule marker, and lactoferrin, a specific granule marker (15), were measured. As observed in Figure 3Go, while the release of lactoferrin was stimulated in response to pathogenic or nonpathogenic mycobacteria, the exocytosis of myeloperoxidase was insignificant except for opsonized M. smegmatis (Fig. 3Go), the effect of which was, however, negligible. This could not be attributed to a defective capacity of neutrophils to release myeloperoxidase, as attested to by the cell response to opsonized zymosan. The possibility that serum opsonization of mycobacteria could elicit the release of myeloperoxidase was tested. As shown in Figure 3Go, neither myeloperoxidase nor lactoferrin secretion was enhanced in response to opsonized mycobacteria. To test the possibility that this phenomenon was restricted to mycobacteria, B. subtilis, another Gram-positive bacterium, was used in parallel. We observed that B. subtilis was ingested by neutrophils with an efficiency similar to mycobacteria (data not shown), but in contrast, it triggered the release of both myeloperoxidase and lactoferrin (Fig. 4Go). Opsonized or nonopsonized B. subtilis induced similar responses (Fig. 4Go). The low level of release of azurophil granule content in the presence of mycobacteria was confirmed using another marker: the lysosomal enzyme ß-glucuronidase (15). Like myeloperoxidase, ß-glucuronidase was efficiently released by neutrophils in response to zymosan or B. subtilis, but only a limited and insignificant release was observed in response to pathogenic and nonpathogenic mycobacteria (Fig. 5Go). During the course of these experiments, cell viability was measured by the release of the cytosolic enzyme lactate dehydrogenase. In control cells or cells exposed to zymosan, the release was 4% and in neutrophils exposed to mycobacteria, 6 to 8%. It is possible that the low level of release of azurophil markers from mycobacteria-infected neutrophils results from the higher percentage of dead neutrophils.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 3. Pathogenic and nonpathogenic mycobacteria trigger the release of lactoferrin but not myeloperoxidase. Neutrophils were stimulated for 40 min as described in the legend to Figure 2Go. The release of lactoferrin, a specific granule marker, and myeloperoxidase, an azurophil granule marker, was measured by ELISA. Results are expressed as mean ± SD of at least four experiments. *, p < 0.05 when compared with control calculated with unpaired Student’s t test.

 


View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 4. B. subtilis stimulates exocytosis of both specific and azurophil granule markers. Neutrophils were stimulated or not (control) with serum-opsonized (ops +) and nonopsonized (ops -) B. subtilis (cell:bacteria ratio, 1:50) for 40 min, and the release of lactoferrin and myeloperoxidase was measured by ELISA. Results are expressed as mean ± SD of five experiments. * p < 0.05 when compared with control calculated with unpaired Student’s t test.

 


View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 5. Mycobacteria do not trigger the release of ß-glucuronidase in neutrophils. Neutrophils were stimulated for 40 min with mycobacteria, B. subtilis (cell:bacteria ratio, 1:50) or 3 mg/ml opsonized zymosan (OZ). The release of ß-glucuronidase is expressed as the percent of the total ß-glucuronidase cell content (mean ± SD of three or four experiments). * p < 0.05 when compared with control calculated with unpaired Student’s t test.

 
The azurophil granule marker myeloperoxidase is not delivered to phagosomes containing mycobacteria

Secretion of granule contents to the external milieu may occur subsequent to granule fusion with unsealed phagosomes. To determine whether the absence or low release of azurophil granule markers in the presence of mycobacteria correlated with a limited fusion with phagosomes, immuno-electron microscopy was performed on neutrophils infected by M. smegmatis and M. kansasii, compared with B. subtilis and zymosan. Figure 6Go shows that myeloperoxidase and lactoferrin were present in phagosomes containing zymosan or B. subtilis. In contrast, phagosomes containing mycobacteria were very poorly stained by anti-myeloperoxidase Abs (Fig. 6Go), whereas they were strongly lactoferrin positive. This finding demonstrates that phagosomes containing mycobacteria are permissive for specific granule fusion but do not fuse with azurophil granules.



View larger version (104K):
[in this window]
[in a new window]
 
FIGURE 6. Lactoferrin, but not myeloperoxidase, is released in mycobacteria-containing phagosomes. Neutrophils were exposed to opsonized zymosan (cell:particle ratio, 1:10), B.subtilis or mycobacteria for 30 min at 37°C (cell:particle ratio, 1:50), washed, and further incubated in particle-free medium for 15 min before fixation. Zymosan, Cryosections of neutrophils infected with opsonized zymosan. Upper panel, Lactoferrin staining (Lf), and lower panel, myeloperoxidase staining (MPO). Phagosomes (ph) are labeled with both markers. Insets, Higher magnification of areas indicated by asterisks. No background labeling is observed in the nucleus (n). Bars = 400 nm; insets = 200 nm. Bacillus, Neutrophils infected with Bacillus subtilis (same as zymosan). Mycobacteria, Neutrophils infected with M. smegmatis (upper panel and lower panel, right) or with M. kansasii (lower panel, left). Phagosomes (ph) containing mycobacteria were highly lactoferrin positive and essentially myeloperoxidase negative; granules (g) are positive for myeloperoxidase. Bar = 400 nm.

 
Neutrophils infected by mycobacteria generate O2-

The possibility that mycobacteria could alter another function contributing to the bactericidal response of neutrophils was investigated. The production of O2- was therefore examined in cells infected by mycobacteria or exposed to zymosan. O2- generation, continuously measured in response to mycobacteria (Fig. 7GoA), increased linearly until a plateau was reached between 90 and 120 min depending on the blood donor. Next, experiments were performed at 40 min to measure the production of O2- at the initial rate. When neutrophils were exposed to pathogenic or nonpathogenic mycobacteria, the O2- generation was elicited to a similar magnitude, and again, serum opsonization of mycobacteria did not affect the results (Fig. 7GoB). We verified the functional assembly of the O2--producing enzyme NADPH oxidase, which requires translocation of cytosolic components to the plasma membrane (32). The presence of the cytosolic components p47phox and p67phox in the membrane fraction of opsonized zymosan-stimulated neutrophils is shown as a positive control (Fig. 7GoC). When neutrophils were exposed to M. smegmatis, p47phox and p67phox became membrane associated (Fig. 7GoC), indicating that NADPH oxidase is assembled in cells exposed to mycobacteria.



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 7. Production of O2- and assembly of NADPH oxidase components in response to mycobacteria. A, Production of O2- in response to zymosan or mycobacteria (50 particles/cell) was continuously measured by the superoxide dismutase-inhibitable reduction of ferricytochrome c. One representative experiment is shown. B, Neutrophils were incubated for 40 min with serum-opsonized (ops +) and nonopsonized (ops -) mycobacteria. In each experiment, cells were stimulated with 3 mg/ml opsonized zymosan (Z) for 20 min; C indicates resting neutrophils. Results are expressed as the mean ± SD of three to five experiments. *, p < 0.05 when compared with control calculated with unpaired Student’s t test. C, NADPH oxidase cytosolic components, p47phox and p67phox, translocate to the plasma membrane of mycobacteria-exposed neutrophils. Resting neutrophils (C for control) or neutrophils stimulated with 3 mg/ml opsonized zymosan for 20 min or with M. smegmatis for 40 min were disrupted and fractionated by differential centrifugation. Proteins from the membrane (m) and cytosol (c) were immunoblotted using rabbit antisera directed against p47phox or p67phox. One representative experiment is shown.

 
The Src tyrosine kinase Hck does not translocate to the phagosomal membrane and is not activated in mycobacteria-infected neutrophils

The Src family tyrosine kinase Hck is associated with the membrane of azurophil granules, is activated during the process of exocytosis, and translocates to the phagosomal membrane (16, 17, 18). Therefore, we investigated whether the translocation of Hck toward phagosomes and its activation occurred during the phagocytosis of mycobacteria. When indirect immunofluorescence was performed, no Hck staining was detectable at the phagosomal membrane around FITC-stained mycobacteria (Fig. 8Go, middle panel), while Hck was clearly present at the phagosomal membrane in neutrophils that had internalized zymosan (Fig. 8Go, upper panel). The possibility that Hck could be present at the phagosomal membrane but hidden by the fluorescence of mycobacteria was ruled out, because similar results were obtained with nonfluorescent M. phlei (data not shown) or when Hck was stained with rhodamine-coupled Abs and mycobacteria stained with FITC (Fig. 8Go, lower panels). When mycobacteria were serum opsonized, Hck did not translocate to the phagosomal membrane either (data not shown).



View larger version (53K):
[in this window]
[in a new window]
 
FIGURE 8. The tyrosine kinase Hck does not translocate to the phagosomal membrane during phagocytosis of mycobacteria. Neutrophils were stimulated with zymosan (upper panel) or FITC-stained mycobacteria (lower panels) for 10 min, fixed and incubated with anti-Hck Abs as described in Materials and Methods (magnification x2000). Upper panel, Following phagocytosis of zymosan particles, neutrophils change their morphology (compare with a); the microscope was focused on Hck-stained phagosomes (arrow) containing zymosan particles, which are located over the cell body. Middle panel, Phagosomes containing FITC-stained mycobacteria are not stained with anti-Hck Abs revealed by FITC-conjugated second Ab, which only stain azurophil granules. Incidentally, a monocyte containing mycobacteria (star) shows a similar Hck staining to neutrophils: granules are stained but not phagosomes. Lower panels: a, Hck stained with rhodamine-coupled secondary Abs in resting neutrophils; b, FITC-stained mycobacteria internalized by a neutrophil; c, the same neutrophil as shown in b, with anti-Hck Abs revealed by rhodamine-conjugated secondary Abs; no phagosome staining can be visualized.

 
The kinase activity of Hck was measured along the process of phagocytosis using either zymosan, M. phlei, or M. kansasii at the same cell:particle ratio. In neutrophils stimulated by zymosan, the kinase was activated with magnitude, and kinetics similar to those observed previously in human neutrophils exposed to opsonized zymosan (18). However, Hck kinase activity remained practically unchanged in response to M. phlei and M. kansasii, except after 20 min of exposure to M. phlei, which induced a significant but negligible increase in the kinase activity (Fig. 9Go). Again, there was no difference between opsonized and nonopsonized M. phlei (results not shown). To determine whether this inhibition was Hck specific, the kinase activity of another Src family tyrosine kinase, Fgr, the expression of which is also restricted to phagocytes (16), was measured. We have previously reported that Fgr is activated during phagocytosis of opsonized zymosan (31). Here, we observed that, during phagocytosis of nonopsonized zymosan, M. phlei, or M. kansasii, Fgr was activated (Fig. 9Go), indicating that not all of the members of the Src family are affected during phagocytosis of mycobacteria. This conclusion was further supported by the observation that Lyn was activated in neutrophils exposed to zymosan or M. phlei (data not shown). Taken together, these results show that, during their phagocytosis, mycobacteria interfere with translocation of Hck to the phagosomes and its activation.



View larger version (33K):
[in this window]
[in a new window]
 
FIGURE 9. Phagocytosis of mycobacteria does not stimulate Hck but activates Fgr. Neutrophils were stimulated with nonopsonized zymosan, M. phlei or M. kansasii (each at 50 particles per cell) for the indicated periods of time. Top, Hck was solubilized and immunoprecipitated from the whole cell lysates, and phosphorylation assays were performed using the exogenous substrate enolase (2.5 x 106 cell equivalents per assay). The histogram represents the amount of 32P incorporated into enolase; data are expressed as mean ± SD of six experiments for M. phlei and three for M. kansasii. Bottom, Kinase activity of Fgr was measured under the same conditions. Data are expressed as mean ± SD of three or four experiments. *, p < 0.05 when compared with control (0 time point) calculated with unpaired Student’s t test.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although neutrophils play a defensive role during mycobacterial infections (11, 12, 13), very few data regarding bactericidal responses of neutrophils toward mycobacteria are available (19, 20, 21, 22), and no comparative studies between pathogenic and nonpathogenic bacteria have been performed. We show here that both pathogenic and nonpathogenic mycobacteria are internalized by neutrophils. Opsonization enhanced phagocytosis without enhancing either the level of O2- production or the exocytosis of specific granule content, suggesting that that there is no obvious relationship between the rate of phagocytosis and the magnitude of the bactericidal responses induced by mycobacteria. In contrast, neutrophil responses to zymosan can be enhanced by opsonins (33), and generation of O2- was 2.5-fold greater with opsonized zymosan than with zymosan (each used at 50 particles per neutrophil; data not shown). At present, we cannot explain why the neutrophil responses reported here are not amplified when mycobacteria are serum opsonized.

Neutrophils contain granules that are secreted during the host’s defense against microbial pathogens. Under physiopathologic conditions, whereas exocytosis of specific granules is initiated by soluble or particulate stimuli, azurophil granules are mobilized when cells perform phagocytosis of particles (1, 14). Once neutrophils start to phagocytose, specific granules fuse with phagosomes and the plasma membrane (14, 34). Azurophil granules are also promptly mobilized and fuse with nascent, unclosed phagosomes (35, 36). Therefore, the presence of azurophil granule markers in the extracellular medium could reflect their fusion with unsealed phagosomes (14, 36). This is in contrast with macrophages in which maturation of phagosomes is required to make them competent for fusion with lysosomes (37, 38). In the present report, we have investigated the mobilization of neutrophil granules in response to both pathogenic and nonpathogenic mycobacteria. Regardless of the mycobacterial species, the specific granule content was released, whereas azurophil granules were very poorly or not at all mobilized. When B. subtilis and mycobacteria were used at the same bacteria:cell ratio, they were internalized with similar efficiency, but exocytosis of azurophil granule markers was detected only in response to B. subtilis. Immuno-electron microscopy confirmed the lack of azurophil granule fusion, showing that phagosomes containing either pathogenic or nonpathogenic mycobacteria were essentially myeloperoxidase negative, whereas phagosomes containing zymosan or B. subtilis were myeloperoxidase positive. In macrophages, inhibition of the fusion between lysosomes and phagosomes has been essentially studied with pathogenic species (M. microti, M. marinum, M. avium, and M. tuberculosis) (5, 6, 7, 8, 9, 10). A report on the nonpathogenic species Mycobacterium aurum shows that lysosome-phagosome fusions are comparable with that of M. avium after a 24-h infection (7). In the light of our results on neutrophils, it would be important to further investigate the release of lysosomal markers in macrophages infected with nonpathogenic mycobacteria to establish whether this inhibition is restricted to pathogenic species. This knowledge would be helpful in the understanding of mycobacterial pathogenicity.

Attempts have been made to identify membrane-associated proteins that could differentially regulate the mobilization and fusion of specific and azurophil granules. We and others have shown that several proteins, due to their unique localization on azurophil or specific granule membranes, may be implicated in these regulations (14, 15, 17, 24, 26). Until now, only two proteins that could play a role in exocytosis have been identified on the surface of azurophil granules: leukophysin, a protein related to synaptophysin (39), and the tyrosine kinase Hck (17). The exocytosis of azurophil granules is inhibited by tyrosine kinase inhibitors (16). Moreover, Hck, which is mainly expressed in phagocytes, is associated with the membrane of azurophil granules, translocates to the phagosomal membrane during internalization of either opsonized zymosan (17, 18) or zymosan (this report), and is concomitantly activated (18). When neutrophils are activated by FMLP or PMA, which induce activation of NADPH oxidase and the release of specific but not of azurophil granules, Hck is not activated (18). In contrast to soluble stimuli, which do not or only poorly mobilize azurophil granules, phagocytosis of particles is accompanied by secretion of this granule type. Here we show that when mycobacteria are phagocytosed by neutrophils, there is almost no release of azurophil granule markers in the extracellular space or inside phagosomes. Under these consitions, Hck does not translocate to the phagosomal membrane, and its level of tyrosine kinase activity remains very low. Taken together, these results support the hypothesis that Hck might play a critical role in the mobilization of azurophil granules toward phagosomes. In HL60 cells differentiated in macrophages and in human monocytes, Hck is also present on cytoplasmic granules, probably lysosomes (17). It is possible, therefore, that Hck is also implicated in the regulation of lysosome mobilization in these cells. Protein phosphorylation on tyrosine residues during phagolysosome biogenesis has been observed on phagosomes isolated from murine macrophages (40). Interestingly, we have previously shown that during the mobilization of azurophil granules in response to phagocytosis of opsonized zymosan, Hck is activated in the azurophil granule fraction but also in the fraction enriched in phagosomes. Therefore, these data strongly suggest that Hck could phosphorylate substrates on phagosomes and/or on azurophil granules. Identification of these proteins will help the understanding of the function of Hck.

To explain why Hck is not activated when neutrophils internalize mycobacteria, one could postulate that membrane receptors involved in their phagocytosis do not evoke signalization for Hck activation. However, this seems unlikely because zymosan and opsonized zymosan use distinct receptors, possibly the lectin site of CR3 (41) and a putative ß-glucan receptor (42) for the former and complement and IgG receptors (43) for the latter; but in both cases, similar Hck activation is observed (see Ref. 18 and this report). Moreover, opsonized or nonopsonized mycobacteria use distinct receptors (2, 44) but do not trigger Hck activation, suggesting that the control of Hck tyrosine kinase activity during phagocytosis might be independent of the receptor used. Alternatively, mycobacteria could either interfere with downstream receptor degranulation signals or directly inhibit Hck. Recently, a factor located in the periplasmic compartment of Escherichia coli and secreted in the culture medium, which is inhibitory for the Src family tyrosine kinase p56lck, has been identified (45). A similar activity, with a tropism for Hck, given that Fgr and Lyn were not affected, could also exist in mycobacteria. This possibility is currently under investigation in our laboratory.

In conclusion, our results show that when human neutrophils are exposed to mycobacteria, they exhibit the typical early bactericidal responses: phagocytosis, generation of O2-, and exocytosis of specific granules. In contrast, mobilization of azurophil granules is not triggered by mycobacteria even when they are opsonized. This is an important finding as it shows that phagocytosis and fusion of azurophil granule with phagosomes can be dissociated events that are uncoupled by mycobacteria. In addition, we demonstrate that neutrophils exhibit similar bactericidal responses to opsonized or nonopsonized, pathogenic and nonpathogenic mycobacteria. Finally, we propose that Hck could be one of the key elements of the secretory pathway that are altered during phagocytosis of mycobacteria.


    Acknowledgments
 
We thank Hans Janssen for technical assistance with the electron microscopy and Nico Ong for the preparation of the micrographs. We gratefully acknowledge Marie-Antoinette Lanéelle and Patricia Constant for fruitful discussions and expert advice and Toon Stegmann for critical reading of the manuscript.


    Footnotes
 
1 This work was supported in part by the Région Midi-Pyrénées (Grant 9609714), Association Recherche et Partage, Ministère de la Recherche ACC SV6, and Centre National de la Recherche Scientifique Programme de Biologie Cellulaire. Back

2 Address correspondence and reprint requests to Dr. I. Maridonneau-Parini, CNRS, IPBS, 205 route de Narbonne, 31077 Toulouse Cedex, France. E-mail address: Back

Received for publication February 26, 1998. Accepted for publication June 25, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Gallin, J.I., I. M. Goldstein, R. Snyderman. 1992. Inflammation: Basic Principles and Clinical Correlates 2nd Ed. Raven Press, New York.
  2. Schlesinger, L. S.. 1996. Role of mononuclear phagocytes in M. tuberculosis pathogenesis. J. Invest. Med. 44:312.[Medline]
  3. Campo, R. E., C. E. Campo. 1997. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24:1233.[Medline]
  4. Pozniak, A.L., A. H. C. Uttley, R. J. Kent. 1996. Mycobacterium avium complex in AIDS: who, when, where, why and how?. J. Appl. Bacteriol. 81:40S.
  5. Lowrie, D. B., V. R. Aber, P. S. Jackett. 1979. Phagosome-lysosome fusion and cyclic adenosine 3'-5'-monophosphate in macrophages infected with Mycobacterium microti, Mycobacterium bovis BCG or Mycobacterium lepraemurium. J. Gen. Microbiol. 110:431.[Abstract/Free Full Text]
  6. Barker, L. P., K. M. George, S. Falkow, P. L. C. Small. 1997. Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect. Immun. 65:1497.[Abstract]
  7. Frehel, C., C. de Chastellier, T. Lang, N. Rastogi. 1986. Evidence for inhibition of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect. Immun. 52:252.[Abstract/Free Full Text]
  8. Xu, S., A. Cooper, S. Sturgill-Kosycki, T. van Heyningen, D. Chatterjee, I. Orme, P. Allen, D. G. Russell. 1994. Intracellular trafficking in Mycobacterium tuberculosis- and Mycobacterium avium-infected macrophages. J. Immunol. 153:2568.[Abstract]
  9. Armstrong, J. A., P. D’Arcy Hart. 1975. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. J. Exp. Med. 142:1.[Abstract/Free Full Text]
  10. Clemens, D. L., M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:257.[Abstract/Free Full Text]
  11. Montgomery, L. G., W. S. Lemon. 1933. The cellular reaction of the pleura to infection with Mycobacterium tuberculosis. J. Thorac. Surg. 11:429.
  12. Appelberg, R., A. G. Castro, S. Gomes, J. Pedrosa, M. T. Silva. 1995. Susceptibility of Beige mice to Mycobacterium avium: role of neutrophils. Infect. Immun. 63:3381.[Abstract]
  13. Saunders, B. M., C. Cheers. 1996. Intranasal infection of Beige mice with Mycobacterium avium complex: role of neutrophils and natural killer cells. Infect. Immun. 64:4236.[Abstract]
  14. Tapper, H.. 1996. The secretion of preformed granules by macrophages and neutrophils. J. Leukocyte Biol. 59:613.[Abstract]
  15. Borregaard, N., J. B. Cowland. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503.[Free Full Text]
  16. Welch, H., C. Mauran, I. Maridonneau-Parini. 1996. Nonreceptor protein-tyrosine kinases in neutrophil activation. Methods 9:607.[Medline]
  17. Möhn, H., V. Le Cabec, S. Fischer, I. Maridonneau-Parini. 1995. The src-family protein-tyrosine kinase p59hck is located on the secretory granules in human neutrophils and translocates towards the phagosome during cell activation. Biochem. J. 309:657.
  18. Welch, H., I. Maridonneau-Parini. 1997. Hck is activated by opsonized zymosan and A23187 in distinct subcellular fractions of human neutrophils. J. Biol. Chem. 272:102.[Abstract/Free Full Text]
  19. Holzer, T. J., L. Kizlaitis, M. Vachula, C. W. Weaver, B. R. Andersen. 1988. Human phagocytic cells responses to Mycobacterium leprae and Mycobacterium bovis Bacillus Calmette-Guérin. J. Immunol. 141:1701.[Abstract]
  20. Jones, G. S., H. J. Amirault, B. R. Andersen. 1990. Killing of Mycobacterium tuberculosis by neutrophils: a non-oxidative process. J. Infect. Dis. 162:700.[Medline]
  21. May, M. E., P. J. Spagnuolo. 1987. Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Infect. Immun. 55:2304.[Abstract/Free Full Text]
  22. Riedel, D. D., S. E. Kaufmann. 1997. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis. Infect. Immun. 65:4620.[Abstract]
  23. Calafat, J., R. Goldschmeding, P. L. Ringeling, H. Janssen, C. E. van der Schoot. 1990. In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic antibodies in neutrophils and monocytes. Blood 75:242.[Abstract/Free Full Text]
  24. Le Cabec, V., I. Maridonneau-Parini. 1994. Annexin 3 is associated with cytoplasmic granules in neutrophils and monocytes and translocates to the plasma membrane in activated cells. Biochem. J. 303:481.
  25. Gelfand, J. A., A. S. Fauci, I. Green, M. M. Frank. 1976. A simple method for the determination of complement receptor-bearing mononuclear cells. J. Immunol. 116:595.[Abstract/Free Full Text]
  26. Maridonneau-Parini, I., J. de Gunzburg. 1992. Association of rap1 and rap2 proteins with the specific granules of human neutrophils. J. Biol. Chem. 267:6396.[Abstract/Free Full Text]
  27. Hed, J.. 1986. Methods for distinguishing ingested from adhering particles. Methods Enzymol. 132:198.[Medline]
  28. Le Cabec, V., I. Maridonneau-Parini. 1995. Complete and reversible inhibition of NADPH oxidase in human neutrophils by phenylarsine oxide at a step distal to membrane translocation of the enzyme subunits. J. Biol. Chem. 270:2067.[Abstract/Free Full Text]
  29. Maridonneau-Parini, I., S. E. Malawista, H. Stubbe, F. Russo-Marie, B. Polla. 1993. Heat shock in human neutrophils: superoxide generation is inhibited by a mechanism distinct from heat-denaturation of NADPH oxidase and is protected by heat shock proteins in thermotolerant cells. J. Cell. Physiol. 156:204.[Medline]
  30. Grégoire, C., H. Welch, C. Astarie-Dequeker, I. Maridonneau-Parini. 1998. Expression of azurophil and specific granule proteins during differentiation of NB4 cells in neutrophils. J. Cell. Physiol. 175:203.[Medline]
  31. Welch, H., I. Maridonneau-Parini. 1997. Lyn and Fgr are activated in distinct fractions of human granulocytic cells. Oncogene 15:2021.[Medline]
  32. Channock, S. J., J. El Benna, R. M. Smith, B. M. Babior. 1994. The respiratory burst oxidase. J. Biol. Chem. 269:24519.[Free Full Text]
  33. Mantovani, B.. 1975. Different roles for IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes. J. Immunol. 115:15.[Abstract/Free Full Text]
  34. Joiner, K. A., T. Albert, D. Rotrosen. 1989. The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes. J. Cell Biol. 109:2771.[Abstract/Free Full Text]
  35. Tapper, H., S. Grinstein. 1997. Fc receptor-triggered insertion of secretory granules into the plasma membrane of human neutrophils. J. Immunol. 159:409.[Abstract]
  36. Suzaki, E., H. Kobayashi, Y. Kodama, T. Masujima, S. Terakawa. 1997. Video-rate dynamics of exocytic events associated with phagocytosis in neutrophils. Cell Motil. Cytoskeleton 38:215.[Medline]
  37. Beron, W., C. Alvarez-Dominguez, L. Mayorga, P. D. Stahl. 1995. Membrane trafficking along the phagocytic pathway. Trends Cell Biol. 5:100.[Medline]
  38. Desjardins, M., N. N. Nzala, R. Corsini, C. Rondeau. 1997. Maturation of phagosomes is accompanied by changes in their fusion properties and size-selective acquisition of solute materials from endosomes. J. Cell Sci. 110:2303.[Abstract]
  39. Abdelhaleem, M. M., L. Hatskelzon, B. I. Dalal, J. M. Gerrard, A. H. Greenberg. 1991. Leukophysin: a 28-kDa granule membrane protein of leukocytes. J. Immunol. 147:3053.[Abstract]
  40. Emans, N., N. N. Nzala, M. Desjardins. 1996. Protein phosphorylation during phagosome maturation. FEBS Lett. 398:37.[Medline]
  41. Thornton, B. P., V. Vetvicka, M. Pitman, R. C. Goldman, G. D. Ross. 1996. Analysis of the sugar specificity and molecular location of the ß-glucan binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156:1235.[Abstract]
  42. Steadman, R., M. Petersen, N. Topley, D. Williams, N. Matthews, B. Spur, J. D. Williams. 1990. Differential augmentation by recombinant human tumor necrosis factor-{alpha} of neutrophil responses to particulate zymosan and glucan. J. Immunol. 144:2712.[Abstract]
  43. Roos, D., A. M. Bot, M. L. J. van Schaik, M. de Boer, M. R. Daha. 1981. Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations. J. Immunol. 126:433.[Medline]
  44. Stokes, R. W, I. D. Haidl, W. A. Jefferies, D. P. Speert. 1993. Mycobacteria-macrophage interactions: macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J. Immunol. 151:7067.[Abstract]
  45. Berger, S. A., R. K. Morrison, H. J. Ziltener. 1996. Identification of a bacterial inhibitor of protein kinases: mechanism and role in host cell invasion. J. Biol. Chem. 271:23431.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Infect. Immun.Home page
T. Schmitter, S. Pils, S. Weibel, F. Agerer, L. Peterson, A. Buntru, K. Kopp, and C. R. Hauck
Opa Proteins of Pathogenic Neisseriae Initiate Src Kinase-Dependent or Lipid Raft-Mediated Uptake via Distinct Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule Isoforms
Infect. Immun., August 1, 2007; 75(8): 4116 - 4126.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. C. Jacobsen, K. Theilgaard-Monch, E. I. Christensen, and N. Borregaard
Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils
Blood, April 1, 2007; 109(7): 3084 - 3087.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Le Cabec, L. J. Emorine, I. Toesca, C. Cougoule, and I. Maridonneau-Parini
The human macrophage mannose receptor is not a professional phagocytic receptor
J. Leukoc. Biol., June 1, 2005; 77(6): 934 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Villeneuve, M. Gilleron, I. Maridonneau-Parini, M. Daffe, C. Astarie-Dequeker, and G. Etienne
Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process
J. Lipid Res., March 1, 2005; 46(3): 475 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Villeneuve, G. Etienne, V. Abadie, H. Montrozier, C. Bordier, F. Laval, M. Daffe, I. Maridonneau-Parini, and C. Astarie-Dequeker
Surface-exposed Glycopeptidolipids of Mycobacterium smegmatis Specifically Inhibit the Phagocytosis of Mycobacteria by Human Macrophages: IDENTIFICATION OF A NOVEL FAMILY OF GLYCOPEPTIDOLIPIDS
J. Biol. Chem., December 19, 2003; 278(51): 51291 - 51300.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. Borelli, F. Vita, S. Shankar, M. R. Soranzo, E. Banfi, G. Scialino, C. Brochetta, and G. Zabucchi
Human Eosinophil Peroxidase Induces Surface Alteration, Killing, and Lysis of Mycobacterium tuberculosis
Infect. Immun., February 1, 2003; 71(2): 605 - 613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Aleman, A. Garcia, M. A. Saab, S. S. de la Barrera, M. Finiasz, E. Abbate, and M. C. Sasiain
Mycobacterium tuberculosis-Induced Activation Accelerates Apoptosis in Peripheral Blood Neutrophils from Patients with Active Tuberculosis
Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 583 - 592.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
G. Etienne, C. Villeneuve, H. Billman-Jacobe, C. Astarie-Dequeker, M.-A. Dupont, and M. Daffe
The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis
Microbiology, October 1, 2002; 148(10): 3089 - 3100.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Le Cabec, S. Carreno, A. Moisand, C. Bordier, and I. Maridonneau-Parini
Complement Receptor 3 (CD11b/CD18) Mediates Type I and Type II Phagocytosis During Nonopsonic and Opsonic Phagocytosis, Respectively
J. Immunol., August 15, 2002; 169(4): 2003 - 2009.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Grosdent, I. Maridonneau-Parini, M.-P. Sory, and G. R. Cornelis
Role of Yops and Adhesins in Resistance of Yersinia enterocolitica to Phagocytosis
Infect. Immun., August 1, 2002; 70(8): 4165 - 4176.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. O. Kisich, M. Higgins, G. Diamond, and L. Heifets
Tumor Necrosis Factor Alpha Stimulates Killing of Mycobacterium tuberculosis by Human Neutrophils
Infect. Immun., August 1, 2002; 70(8): 4591 - 4599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. P. Scott, F. Zappacosta, E. Y. Kim, R. S. Annan, and W. T. Miller
Identification of Novel SH3 Domain Ligands for the Src Family Kinase Hck. WISKOTT-ALDRICH SYNDROME PROTEIN (WASP), WASP-INTERACTING PROTEIN (WIP), AND ELMO1
J. Biol. Chem., July 26, 2002; 277(31): 28238 - 28246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Carreno, E. Caron, C. Cougoule, L. J. Emorine, and I. Maridonneau-Parini
p59Hck Isoform Induces F-actin Reorganization to Form Protrusions of the Plasma Membrane in a Cdc42- and Rac-dependent Manner
J. Biol. Chem., May 31, 2002; 277(23): 21007 - 21016.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Perskvist, K. Roberg, A. Kulyte, and O. Stendahl
Rab5a GTPase regulates fusion between pathogen-containing phagosomes and cytoplasmic organelles in human neutrophils
J. Cell Sci., March 15, 2002; 115(6): 1321 - 1330.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Cougoule, P. Constant, G. Etienne, M. Daffe, and I. Maridonneau-Parini
Lack of Fusion of Azurophil Granules with Phagosomes during Phagocytosis of Mycobacterium smegmatis by Human Neutrophils Is Not Actively Controlled by the Bacterium
Infect. Immun., March 1, 2002; 70(3): 1591 - 1598.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Tapper, A. Karlsson, M. Morgelin, H. Flodgaard, and H. Herwald
Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles
Blood, March 1, 2002; 99(5): 1785 - 1793.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Astarie-Dequeker, S. Carreno, C. Cougoule, and I. Maridonneau-Parini
The protein tyrosine kinase Hck is located on lysosomal vesicles that are physically and functionally distinct from CD63-positive lysosomes in human macrophages
J. Cell Sci., January 1, 2002; 115(1): 81 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Majeed, E. Caveggion, C. A. Lowell, and G. Berton
Role of Src kinases and Syk in Fc{gamma} receptor-mediated phagocytosis and phagosome-lysosome fusion
J. Leukoc. Biol., November 1, 2001; 70(5): 801 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Hartmann, R. Becker, C. Franzen, E. Schell-Frederick, J. Römer, M. Jacobs, G. Fätkenheuer, and G. Plum
Phagocytosis and killing of Mycobacterium avium complex by human neutrophils
J. Leukoc. Biol., March 1, 2001; 69(3): 397 - 404.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
P. Peyron, C. Bordier, E.-N. N'Diaye, and I. Maridonneau-Parini
Nonopsonic Phagocytosis of Mycobacterium kansasii by Human Neutrophils Depends on Cholesterol and Is Mediated by CR3 Associated with Glycosylphosphatidylinositol-Anchored Proteins
J. Immunol., November 1, 2000; 165(9): 5186 - 5191.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. Le Cabec, C. Cols, and I. Maridonneau-Parini
Nonopsonic Phagocytosis of Zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) Involves Distinct Molecular Determinants and Is or Is Not Coupled with NADPH Oxidase Activation
Infect. Immun., August 1, 2000; 68(8): 4736 - 4745.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Astarie-Dequeker, J. Nigou, G. Puzo, and I. Maridonneau-Parini
Lipoarabinomannans Activate the Protein Tyrosine Kinase Hck in Human Neutrophils
Infect. Immun., August 1, 2000; 68(8): 4827 - 4830.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Francois, V. Le Cabec, M.-A. Dupont, P. J. Sansonetti, and I. Maridonneau-Parini
Induction of Necrosis in Human Neutrophils by Shigella flexneri Requires Type III Secretion, IpaB and IpaC Invasins, and Actin Polymerization
Infect. Immun., March 1, 2000; 68(3): 1289 - 1296.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Perskvist, L. Zheng, and O. Stendahl
Activation of Human Neutrophils by Mycobacterium tuberculosis H37Ra Involves Phospholipase C{gamma}2, Shc Adapter Protein, and p38 Mitogen-Activated Protein Kinase
J. Immunol., January 15, 2000; 164(2): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Astarie-Dequeker, E.-N. N'Diaye, V. Le Cabec, M. G. Rittig, J. Prandi, and I. Maridonneau-Parini
The Mannose Receptor Mediates Uptake of Pathogenic and Nonpathogenic Mycobacteria and Bypasses Bactericidal Responses in Human Macrophages
Infect. Immun., February 1, 1999; 67(2): 469 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Carreno, M.-E. Gouze, S. Schaak, L. J. Emorine, and I. Maridonneau-Parini
Lack of Palmitoylation Redirects p59Hck from the Plasma Membrane to p61Hck-positive Lysosomes
J. Biol. Chem., November 10, 2000; 275(46): 36223 - 36229.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Peyron, I. Maridonneau-Parini, and T. Stegmann
Fusion of Human Neutrophil Phagosomes with Lysosomes in Vitro. INVOLVEMENT OF TYROSINE KINASES OF THE Src FAMILY AND INHIBITION BY MYCOBACTERIA
J. Biol. Chem., September 14, 2001; 276(38): 35512 - 35517.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by N’Diaye, E.-N.
Right arrow Articles by Maridonneau-Parini, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by N’Diaye, E.-N.
Right arrow Articles by Maridonneau-Parini, I.
Right arrowPubmed/NCBI databases
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS